Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Murex settles litigation, incurs loss

This article was originally published in Clinica

Executive Summary

Murex has reported a net loss of $2.2 million in the first quarter ended March 31st, 1995, compared with a net income of $971,000 in the 1994 first quarter. The loss includes a charge of $3.1 million for litigation settlements. Murex and parties to 1992 class action suits and a subsequent action filed in 1994 have settled all claims for $5.4 million, of which Murex will pay a portion. Murex has not admitted liability to the claims, which alleged misrepresentation of company facts and insider trading. The settlement is subject to a definitive agreement and court confirmation.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT091522

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel